Delivery Order SPE2DR25D3016-SPE2DR26FG2AK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count packages) with a ceiling value of $1,013.34. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. The order is scheduled for completion by December 5, 2025, with fulfillment occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count) with a contract value of $1,114.63. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is due for completion by November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,606.82 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. The contract employs firm fixed pricing and is not set aside, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100, with a contract ceiling value of $4,297.24. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,559.10 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,052.07. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,660.44. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively made. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ambien CR 6.25 mg tablets (100-count units) on December 4, 2025, with a contract ceiling value of $2,524.38 and ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packaging) on August 13, 2025, with a ceiling value of $1,715.50 and an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,459.27 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on November 25, 2025, with completion expected by November 26, 2025. This non-competitive delivery order utilizes firm fixed-price pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2AKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100, with a ceiling value of $4,519.31. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contract awards demonstrates capability in supplying a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for sedative medication represents one of numerous competitively awarded transactions the company executes under its prime IDC with DLA, fulfilling ongoing pharmaceutical supply requirements for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 12/8/25 |